Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Finasteride helps reduce heart issues and improves heart function.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

The effects of estrogen on human hair growth are unclear and need more research.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Certain hormone treatments can improve acne and related conditions in women.

Hair loss requires customized treatments based on its various causes and types.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.